Conformational adaptation of apolipoprotein A-I to discretely sized phospholipid complexes

Biochemistry

Volumn 46, Issue 26, 2007, Pages 7811-7821

  Bhat, Shaila ^a   Sorci Thomas, Mary G ^a,b   Tuladhar, Rubina ^a   Samuel, Michael P ^a   Thomas, Michael J ^a  

^a WAKE FOREST BAPTIST HEALTH   (United States)

^b WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONFORMATIONS; CROSSLINKING; MASS SPECTROMETRY; MOLECULAR DYNAMICS; MONOMERS; PHOSPHOLIPIDS;

LIPID-FREE STATE; MOLECULAR DISTANCES; MOLECULAR MODEL; RECOMBINANT PHOSPHOLIPID COMPLEXES (RHDL);

PROTEINS;

2 OLEOYL 1 PALMITOYLPHOSPHATIDYLCHOLINE; ABC TRANSPORTER A1; APOLIPOPROTEIN A1; CYSTEINE; DIMER; MONOMER; MUTANT PROTEIN; PHOSPHOLIPID; TRYPSIN;

AMINO ACID SEQUENCE; ARTICLE; CHOLESTEROL METABOLISM; COMPLEX FORMATION; CROSS LINKING; CRYSTAL STRUCTURE; DIMERIZATION; HUMAN; MOLECULAR MODEL; PARTICLE SIZE; PEPTIDE ANALYSIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; TIME OF FLIGHT MASS SPECTROMETRY;

APOLIPOPROTEIN A-I; CROSS-LINKING REAGENTS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; LIPOPROTEINS, HDL; MODELS, MOLECULAR; PHOSPHATIDYLCHOLINES; PHOSPHOLIPIDS; PROTEIN CONFORMATION; RECOMBINANT PROTEINS; SUCCINIMIDES; TANDEM MASS SPECTROMETRY;

EID: 34347356570     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi700384t     Document Type: Article

References (47)

1. Rader, D. J. (2006) Molecular regulation of HDL metabolism and function: implications for novel therapies, J. Clin. Invest. 116, 3090-3100.
2. Linsel-Nitschke, P., and Tall, A. R. (2005) HDL as a target in the treatment of atherosclerotic cardiovascular disease, Nat. Rev. Drug Discov. 4, 193-205.
3. Oram, J. F., and Heinecke, J. W. (2005) ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease, Physiol. Rev. 85, 1343-1372.
4. Pownall, H. J., and Ehnholm, C. (2006) The unique role of apolipoprotein A-I in HDL remodeling and metabolism, Curr. Opin. Lipidol. 17, 209-213.
5. Saito, H., et al. (2003) Domain structure and lipid interaction in human apolipoproteins A-I and E, a general model, J. Biol. Chem. 278, 23227-23232.
6. Timmins, J. M., et al. (2005) Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I, J. Clin. Invest. 115, 1333-1342.
7. Zannis, V. I., Chroni, A., and Krieger, M. (2006) Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL, J. Mol. Med. 84, 276-294.
8. von Eckardstein, A. (2006) Differential diagnosis of familial high density lipoprotein deficiency syndromes, Atherosclerosis 186, 231-239.
9. Sorci-Thomas, M. G., and Thomas, M. J. (2002) The effects of altered apolipoprotein A-I structure on plasima HDL concentration, Trends Cardiovasc. Med. 12, 121-128.
10. Thuahnai, S. T., et al. (2004) Scavenger receptor class B type I-mediated cholesteryl ester-selective uptake and efflux of unesterified cholesterol. Influence of high density lipoprotein size and structure, J. Biol. Chem. 279, 12448-12455.
11. Connelly, M. A., and Williams, D. L. (2004) SR-BI and HDL cholesteryl ester metabolism, Endocr. Res. 30, 697-703.
12. Segrest, J. P., et al. (1992) The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function, J. Lipid Res. 33, 141-166.
13. Li, L., et al. (2004) Double belt structure of discoidal high density lipoproteins: molecular basis for size heterogeneity, J. Mol. Biol. 343, 1293-1311.
14. Borhani, D. W., et al. (1997) Crystal structure of truncated human apolipoprotein A-I suggests a lipid-bound conformation, Proc. Natl. Acad. Sci. U.S.A. 94, 12291-12296.
15. Palgunachari, M. N., et al. (1996) Only the two end helixes of eight tandem amphipathic helical domains of human apo A-I have significant lipid affinity - Implications for HDL assembly, Arterioscler. Thromb. Vasc. Biol. 16, 328-338.
16. Zhu, H. L., and Atkinson, D. (2007) Conformation and lipid binding of a C-terminal (198-243) peptide of human apolipoprotein A-I, Biochemistry 46, 1624-1634.
17. Zhu, H. L., and Atkinson, D. (2004) Conformation and lipid binding of the N-terminal (1-44) domain of human apolipoprotein A-I, Biochemistry 43, 13156-13164.
18. Beckstead, J. A., et al. (2005) Combined N- and C-terminal truncation of human apolipoprotein A-I yields a folded, functional central domain, Biochemistry 44, 4591-4599.
19. Lagerstedt, J. O., et al. (2007) EPR spectroscopy of site-directed spin labels reveals the structural heterogeneity in the N-terminal domain of apo-AI in solution, J. Biol. Chem. (in press).
20. Oda, M. N., et al. (2003) The C-terminal domain of apolipoprotein A-I contains a lipid-sensitive conformational trigger, Nat. Struct. Biol. 10, 455-460.
21. Saito, H., et al. (2004) Alpha-helix formation is required for high affinity binding of human apolipoprotein A-I to lipids, J. Biol. Chem. 279, 20974-20981.
22. Fang, Y. L., Gursky, O., and Atkinson, D. (2003) Lipid-binding studies of human apolipoprotein A-I and its terminally truncated mutants, Biochemistry 42, 13260-13268.
23. Fang, Y., Gursky, O., and Atkinson, D. (2003) Structural studies of N- and C-terminally truncated human apolipoprotein A-I, Biochemistry 42, 6881-6890.
24. Tanaka, M., et al. (2006) Contributions of the N- and C-terminal helical segments to the lipid-free structure and lipid interaction of apolipoprotein A-I, Biochemistry 45, 10351-10358.
25. Scott, B. R., et al. (2001) The N-terminal globular domain and the first class A amphipathic helix of apolipoprotein A-I are important for lecithinxholesterol acyltransferase activation and the maturation of high denisty lipoprotein in vivo, J. Biol. Chem. 276, 48716-48724.
26. Chroni, A., et al. (2003) The central helices of ApoA-I can promote ATP-binding cassette transporter A1 (ABCA1)-mediated lipid efflux. Amino acid residues 220-231 of the wild-type ApoA-I are required for lipid efflux in vitro and high density lipoprotein formation in vivo, J. Biol. Chem. 278, 6719-6730.
27. Ajees, A. A., et al. (2006) Crystal structure of human apolipoprotein A-I: Insights into its protective effect against cardiovascular diseases, Proc. Natl. Acad. Sci. U.S.A. (in press).
28. Klon, A. E., Segrest, J. P., and Harvey, S. C. (2002) Comparative models for human apolipoprotein A-I bound to lipid in discoidal high-density lipoprotein particles, Biochemistry 41, 10895-10905.
29. Davidson, W. S., and Silva, R. A. (2005) Apolipoprotein structural organization in high density lipoproteins: belts, bundles, hinges and hairpins, Curr. Opin. Lipidol. 16, 295-300.
30. Young, M. M., et al. (2000) High throughput protein fold identification by using experimental constraints derived from intramolecular cross-links and mass spectrometry, Proc. Natl. Acad. Sci. U.S.A. 97, 5802-5806.
31. Davidson, W. S., and Hilliard, G. M. (2003) The spatial organization of apolipoprotein A-I on the edge of discoidal high density lipoprotein particles - A mass spectrometry study, J. Biol. Chem. 278, 27199-27207.
32. Bhat, S., et al. (2005) Intermolecular contact between globular N-terminal fold and C-terminal domain of ApoA-I stabilizes its lipid-bound conformation: studies employing chemical cross-linking and mass spectrometry, J. Biol. Chem. 280, 33015-33025.
33. Silva, R. A., et al. (2005) A mass spectrometric determination of the conformation of dimeric apolipoprotein A-I in discoidal high density lipoproteins, Biochemistry 44, 8600-8607.
34. Segrest, J. P., et al. (2000) Structure and function of apolipoprotein A-I and high-density lipoprotein, Curr. Opin. Lipidol. 11, 105-115.
35. Maiorano, J. N., et al. (2004) Identification and structural ramifications of a hinge domain in apolipoprotein A-I discoidal high-density lipoproteins of different size, Biochemistry 43, 11717-11726.
36. Nichols, A. V., et al. (1976) Effects of guanidine hydrochloride on human plasma high density lipoproteins, Biochim. Biophys. Acta 446, 226-239.
37. Li, H. H., et al. (2000) Structural determination of lipid-bound ApoA-I using fluorescence resonance energy transfer, J. Biol. Chem. 275, 37048-37054.
38. Alexander, E. T., et al. (2005) Apolipoprotein A-I helix 6 negatively charged residues attenuate lecithinxholesterol acyltransferase (LCAT) reactivity, Biochemistry 44, 5409-5419.
39. Sorci-Thomas, M. G., et al. (1996) High level secretion of wild-type and mutant forms of human proapoA-I using baculovirus-mediated Sf-9 cell expression, J. Lipid Res. 37, 673-683.
40. MacFarlane, A. S. (1958) Efficient trace-labeling of proteins with iodine, Nature 182, 53.
41. Zhu, Z. B., Atkinson, T. P., and Volanakis, J. E. (1998) A novel type II complement C2 deficiency allele in an African-American family, J. Immunol. 161, 578-584.
42. Reynolds, J. A., and Tanford, C. (1970) The gross conformation of protein-sodium dodecyl sulfate complexes, J. Biol. Chem. 245, 5161-5165.
43. Manning, M., and Colon, W. (2004) Structural basis of protein kinetic stability: resistance to sodium dodecyl sulfate suggests a central role for rigidity and a bias toward beta-sheet structure, Biochemistry 43, 11248-11254.
44. Martin, D. D., et al. (2006) Apolipoprotein A-I assumes a "looped belt" conformation on reconstituted high density lipoprotein, J. Biol. Chem. 281, 20418-20426.
45. Catte, A., et al. (2006) Novel changes in discoidal high density lipoprotein morphology: a molecular dynamics study, Biophys. J. 90, 4345-4360.
46. Roberts, L. M., et al. (1997) Structural analysis of apolipoprotein A-I: Limited proteolysis of methionine-reduced and -oxidized lipid-free and lipid-bound human apo A-I, Biochemistry 36, 7615-7624.
47. Calabresi, L., et al. (2001) Limited proteolysis of a disulfide-linked apoA-I dimer in reconstituted HDL, J. Lipid Res. 42, 935-942.